The objective of this educational initiative is to provide evidence-based information on the latest developments in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC), including updates on EGFR tyrosine kinase inhibitors (TKIs), as well as the importance of EGFR mutation testing, including molecular profiling using circulating tumor DNA (ctDNA) for tailoring therapy and improving patient outcomes. Practical strategies for using some of the newer therapies as well as companion diagnostic testing and technologies to detect EGFR mutations from ctDNA in advanced NSCLC patients will be incorporated into this Grand Rounds series. This initiative is targeted toward clinicians involved in the care of patients with advanced lung cancer, specifically physicians, nurses, and pharmacists specializing/practicing in academic or community hospitals.

View All Speakers


Lecia Sequist, MD, MPH

Associate Professor of Medicine Harvard Medical School Massachusetts General Hospital Cancer Center Boston, MA
View Full Bio

Corey Langer, MD, FACP

Professor of Medicine Hematology/Oncology Division University of Pennsylvania Philadelphia, PA
View Full Bio

Justin Gainor, MD

Instructor in Medicine Harvard Medical School Boston, MA
View Full Bio

Hossein Borghaei, DO

Chief, Thoracic Medical Oncology Director, Lung Cancer Risk Assessment Fox Chase Cancer Center Philadelphia, PA
View Full Bio

Mark Kris, MD, FACP, FACCP

Attending Physician, Thoracic Oncology Service The William and Joy Ruane Chair in Thoracic Oncology Lead Physician, Memorial Sloan Kettering–IBM Watson Collaboration Memorial Sloan Kettering Cancer Center Professor of Medicine Weill Cornell Medical College New York, NY
View Full Bio

Jack West, MD

Medical Director Thoracic Oncology Program Swedish Cancer Institute Web Editor, JAMA Oncology Founder & President GRACE: Global Resource for Advancing Cancer Education Seattle, WA
View Full Bio

Paul Bunn, Jr., MD, FASCO

Distinguished Professor James Dudley Endowed Chair of Lung Cancer Research Division of Medical Oncology University of Colorado Cancer Center University of Colorado, School of Medicine Aurora, CO
View Full Bio

Vassiliki Papadimitrakopoulou, MD

Chief, Section of Thoracic Medical Oncology Jay and Lori Eisenberg Distinguished Professor of Medicine Department of Thoracic/Head and Neck Medical Oncology The University of Texas MD Anderson Cancer Center Houston, TX
View Full Bio

Tom Stinchcombe, MD

Division of Medical Oncology Duke University Medical Center Durham, NC
View Full Bio

Suresh Ramalingam, MD

(Activity Chair) Professor of Hematology and Medical Oncology Director, Division of Medical Oncology Assistant Dean for Cancer Research Emory University School of Medicine Deputy Director, Winship Cancer Institute Atlanta, GA
View Full Bio

Ramaswamy Govindan, MD

Director of Medical Oncology Division of Oncology Professor of Medicine Department of Medicine Washington University School of Medicine St. Louis, MO
View Full Bio

Naiyer Rizvi, MD

Professor of Medicine Director, Thoracic Oncology and Immunotherapeutics Division of Hematology and Oncology Columbia University Medical Center New York, NY
View Full Bio

David Gandara, MD

Professor of Medicine Division of Hematology/Oncology University of California, Davis School of Medicine Director, Thoracic Oncology Program Senior Advisor to the Director UC Davis Comprehensive Cancer Center Sacramento, CA
View Full Bio

Fred Hirsch, MD, PhD

Professor of Medicine and Pathology University of Colorado, School of Medicine Associate Director University of Colorado Cancer Center Denver, CO
View Full Bio

Mark Socinski, MD

Executive Medical Director Florida Hospital Cancer Institute Orlando, FL
View Full Bio


In support of improving patient care, Creative Educational Concepts is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Medicine (ACCME)
CEC designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacy (ACPE)
This application-based activity is approved for 1.0 contact hour (.10 CEUs) of continuing pharmacy education credit (UAN 0245-0000-16-003-L01-P).

Nursing (ANCC)
This activity is designated for 1.0 contact hour.
Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.

Upon completion of a CE request form, statements of credit for physicians and nurses will be issued via email within 30 business days. Pharmacy credit will be reported directly to the National Association of Boards of Pharmacy®(NABP®) CPE Monitor electronic CE tracking system.


This activity is presented by Creative Educational Concepts and supported by an independent educational grant from AstraZeneca.